Integrated Filing — IndAS

General information about company
Scrip Code	539871
NSE Symbol	THYROCARE
MSEI Symbol	NOTLISTED
ISIN	INE594H01019
Name of company	Thyrocare Technologies Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	23-Apr-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	15-Apr-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Consolidated
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Multi segment
Description of single segment
Start date and time of board meeting	23-Apr-2025   15:00:00
End date and time of board meeting	23-Apr-2025   16:01:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	1871600000	6873500000
	Other income	45900000	148300000
	Total income	1917500000	7021800000
2	Expenses
(a)	Cost of materials consumed	487100000	1882700000
(b)	Purchases of stock-in-trade	4600000	20000000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	3000000	8100000
(d)	Employee benefit expense	334700000	1267700000
(e)	Finance costs	7000000	30500000
(f)	Depreciation, depletion and amortisation expense	137700000	552600000
(f)	Other Expenses
1	Other expenses	465200000	1791400000
	Total other expenses	465200000	1791400000
	Total expenses	1439300000	5553000000
3	Total profit before exceptional items and tax	478200000	1468800000
4	Exceptional items	0	0
5	Total profit before tax	478200000	1468800000
6	Tax expense
7	Current tax	143400000	478200000
8	Deferred tax	112800000	68700000
9	Total tax expenses	256200000	546900000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	222000000	921900000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	-6300000	-14400000
16	Total profit (loss) for period	215700000	907500000
17	Other comprehensive income net of taxes	-2300000	-7700000
18	Total Comprehensive Income for the period	213400000	899800000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent	217000000	915100000
	Total profit or loss, attributable to non-controlling interests	-1300000	-1300000
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	214700000	907400000
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	-1300000	-7600000
21	Details of equity share capital
	Paid-up equity share capital	529900000	529900000
	Face value of equity share capital	10	10
27	Details of debt securities
22	Reserves excluding revaluation reserve		4937600000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	4.17	17.13
	Diluted earnings (loss) per share from continuing operations	4.16	17.08
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	4.17	17.13
	Diluted earnings (loss) per share from continuing and discontinued operations	4.16	17.08
24	Debt equity ratio	0.0005	0.0027
25	Debt service coverage ratio	0	0
26	Interest service coverage ratio	0	0
27	Disclosure of notes on financial results

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Consolidated
	Assets
1	Non-current assets
	Property, plant and equipment	1487100000
	Capital work-in-progress	141500000
	Investment property	0
	Goodwill	1082100000
	Other intangible assets	48400000
	Intangible assets under development	0
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	241700000
	Non-current financial assets
	Non-current investments	0
	Trade receivables, non-current	0
	Loans, non-current	0
	Other non-current financial assets	78900000
	Total non-current financial assets	78900000
	Deferred tax assets (net)	85300000
	Other non-current assets	385300000
	Total non-current assets	3550300000
2	Current assets
	Inventories	465400000
	Current financial asset
	Current investments	1373600000
	Trade receivables, current	730000000
	Cash and cash equivalents	176800000
	Bank balance other than cash and cash equivalents	368000000
	Loans, current	0
	Other current financial assets	11500000
	Total current financial assets	2659900000
	Current tax assets (net)	0
	Other current assets	251900000
	Total current assets	3377200000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	6927500000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	529900000
	Other equity	4937600000
	Total equity attributable to owners of parent	5467500000
	Non controlling interest	3000000
	Total equity	5470500000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	0
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	169200000
	Total non-current financial liabilities	169200000
	Provisions, non-current	69400000
	Deferred tax liabilities (net)	0
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	238600000
	Current liabilities
	Current financial liabilities
	Borrowings, current	0
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	28100000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	734000000
	Total Trade payable	762100000
	Other current financial liabilities	243600000
	Total current financial liabilities	1005700000
	Other current liabilities	178900000
	Provisions, current	10000000
	Current tax liabilities (Net)	23800000
	Deferred government grants, Current	0
	Total current liabilities	1218400000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	1457000000
	Total equity and liabilites	6927500000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Consolidated	Consolidated
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
1	Diagnostic Testing Services	1726900000	6296900000
2	Imaging Services	136800000	542900000
3	Others	7900000	33700000
	Total Segment Revenue	1871600000	6873500000
	Less: Inter segment revenue	0	0
	Revenue from operations	1871600000	6873500000
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
1	Diagnostic Testing Services	411700000	1355100000
2	Imaging Services	20200000	-40200000
3	Others	300000	5700000
	Total Profit before tax	432200000	1320600000
	i. Finance cost	0	0
	ii. Other Unallocable Expenditure net off Unallocable income	-39600000	-39600000
	Profit before tax	471800000	1454400000
3	(Segment Asset - Segment Liabilities)
	Segment Asset
1	Diagnostic Testing Services	4805400000	4805400000
2	Imaging Services	1795200000	1795200000
3	Others	0	0
	Total Segment Asset	6600600000	6600600000
	Un-allocable Assets	326900000	326900000
	Net Segment Asset	6927500000	6927500000
4	Segment Liabilities
	Segment Liabilities
1	Diagnostic Testing Services	1087300000	1087300000
2	Imaging Services	107300000	107300000
3	Others	0	0
	Total Segment Liabilities	1194600000	1194600000
	Un-allocable Liabilities	23800000	23800000
	Net Segment Liabilities	1218400000	1218400000
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
	Total Amount of items that will not be reclassified to profit and loss
2	Income tax relating to items that will not be reclassified to profit or loss	3100000	10300000
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	-800000	-2600000
5	Total Other comprehensive income	-2300000	-7700000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Consolidated
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			1468800000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			30600000
	Adjustments for decrease (increase) in inventories			9900000
	Adjustments for decrease (increase) in trade receivables, current			-307900000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			-153500000
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			0
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			361000000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			202900000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			552600000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			13000000
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			0
	Adjustments for other financial liabilities, non-current			12600000
	Adjustments for unrealised foreign exchange losses gains			0
	Adjustments for dividend income			0
	Adjustments for interest income			19800000
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			-10900000
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			0
	Other adjustments to reconcile profit (loss)			-77400000
	Other adjustments for non-cash items			245100000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			858200000
	Net cash flows from (used in) operations			2327000000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			413800000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			1913200000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			112500000
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			100000
	Purchase of property, plant and equipment			448900000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			82000000
	Purchase of other long-term assets			65600000
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			19700000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) investing activities	-525200000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			400000
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			0
	Repayments of borrowings			215900000
	Payments of lease liabilities			131300000
	Dividends paid			953100000
	Interest paid			4300000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			-1304200000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			83800000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			83800000
	Cash and cash equivalents cash flow statement at beginning of period			93000000
	Cash and cash equivalents cash flow statement at end of period			176800000